Betaine attenuates hepatic steatosis by reducing methylation of the MTTP promoter and elevating genomic methylation in mice fed a high-fat diet

Journal of Nutritional Biochemistry

Volumn 25, Issue 3, 2014, Pages 329-336

  Wang, Li jun ^a   Zhang, Hong wei ^a   Zhou, Jing ya ^a   Liu, Yan ^a   Yang, Yang ^a   Chen, Xiao ling ^a   Zhu, Cui hong ^a   Zheng, Rui dan ^b   Ling, Wen hua ^a   Zhu, Hui lian ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Digestive Endoscopy Center of Nanjing Military Command   (China)

Author keywords

Betaine; DNA methylation; Methylation capacity; Microsomal triglyceride transfer protein; Nonalcoholic fatty liver disease

Indexed keywords

BETAINE; DNA METHYLATION; METHYLATION CAPACITY; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; NONALCOHOLIC FATTY LIVER DISEASE;

ANIMALS; BETAINE; DIET, HIGH-FAT; DNA METHYLATION; FATTY LIVER; MALE; MICE; MICE, INBRED C57BL; PROMOTER REGIONS, GENETIC; THYMINE NUCLEOTIDES;

EID: 84893798702     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.11.007     Document Type: Article

References (41)

1. Yoshihisa T., Yurie S., Toshio F. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2012, 18:2300-2308.
2. Leone T.C., Weinheimer C.J., Kelly D.P. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A 1999, 96:7473-7478.
3. Zhu L., Baker S.S., Liu W., Tao M.H., Patel R., Nowak N.J., et al. Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis. Metabolism 2011, 60:1001-1011.
4. Li Y.Y. Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease. World J Gastroenterol 2012, 18:6546-6551.
5. Stidley C.A., Picchi M.A., Leng S., Willink R., Crowell R.E., Flores K.G., et al. Multivitamins, folate, and green vegetables protect against gene promoter methylation in the aerodigestive tract of smokers. Cancer Res 2010, 70:568-574.
6. Tryndyak V.P., Han T., Muskhelishvili L., Fuscoe J.C., Ross S.A., Beland F.A., et al. Coupling global methylation and gene expression profiles reveal key pathophysiological events in liver injury induced by a methyl-deficient diet. Mol Nutr Food Res 2011, 55:411-418.
7. Kim S., Sohn I., Ahn J.I., Lee K.H., Lee Y.S., Lee Y.S. Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. Gene 2004, 340:99-109.
8. Song Z., Deaciuc I., Zhou Z., Song M., Chen T., Hill D., et al. Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis. Am J Physiol Gastrointest Liver Physiol 2007, 293:G894-G902.
9. Achon M., Alonso-Aperte E., Reyes L., Ubeda N., Varela-Moreiras G. High-dose folic acid supplementation in rats: effects on gestation and the methionine cycle. Br J Nutr 2000, 83:177-183.
10. Niculescu M.D., Zeisel S.H. Diet, methyl donors and DNA methylation: interactions between dietary folate, methionine and choline. J Nutr 2002, 132:2333S-2335S.
11. Jacob R.A., Gretz D.M., Taylor P.C., James S.J., Pogribny I.P., Miller B.J., et al. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J Nutr 1998, 128:1204-1212.
12. Wang Z., Yao T., Pini M., Zhou Z., Fantuzzi G., Song Z. Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol 2010, 298:G634-G642.
13. Kwon D.Y., Jung Y.S., Kim S.J., Park H.K., Park J.H., Kim Y.C. Impaired sulfur-amino acid metabolism and oxidative stress in nonalcoholic fatty liver are alleviated by betaine supplementation in rats. J Nutr 2009, 139:63-68.
14. Kathirvel E., Morgan K., Nandgiri G., Sandoval B.C., Caudill M.A., Bottiglieri T., et al. Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine. Am J Physiol Gastrointest Liver Physiol 2010, 299:G1068-G1077.
15. Abdelmalek M.F., Sanderson S.O., Angulo P., Soldevila-Pico C., Liu C., Peter J., et al. Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial. Hepatology 2009, 50:1818-1826.
16. Abdelmalek M.F., Angulo P., Jorgensen R.A., Sylvestre P.B., Lindor K.D. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. Am J Gastroenterol 2001, 96:2711-2717.
17. Chang X., Yan H., Fei J., Jiang M., Zhu H., Lu D., et al. Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats. J Lipid Res 2010, 51:2504-2515.
18. Kang X., Zhong W., Liu J., Song Z., McClain C.J., Kang Y.J., et al. Zinc supplementation reverses alcohol-induced steatosis in mice through reactivating hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor- alpha. Hepatology 2009, 50:1241-1250.
19. Quesada H., Del B.J., Pajuelo D., Diaz S., Fernandez-Larrea J., Pinent M., et al. Grape seed proanthocyanidins correct dyslipidemia associated with a high-fat diet in rats and repress genes controlling lipogenesis and VLDL assembling in liver. Int J Obes (Lond) 2009, 33:1007-1012.
20. Wang L., Chen L., Tan Y., Wei J., Chang Y., Jin T., et al. Betaine supplement alleviates hepatic triglyceride accumulation of apolipoprotein E deficient mice via reducing methylation of peroxisomal proliferator-activated receptor alpha promoter. Lipids Health Dis 2013, 12:34.
21. Holm P.I., Ueland P.M., Kvalheim G., Lien E.A. Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry. Clin Chem 2003, 49:286-294.
22. Nolin T.D., McMenamin M.E., Himmelfarb J. Simultaneous determination of total homocysteine, cysteine, cysteinylglycine, and glutathione in human plasma by high-performance liquid chromatography: application to studies of oxidative stress. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 852:554-561.
23. Wang W., Kramer P.M., Yang S., Pereira M.A., Tao L. Reversed-phase high-performance liquid chromatography procedure for the simultaneous determination of S-adenosyl-l-methionine and S-adenosyl-l-homocysteine in mouse liver and the effect of methionine on their concentrations. J Chromatogr B Biomed Sci Appl 2001, 762:59-65.
24. Jiang M., Zhang Y., Fei J., Chang X., Fan W., Qian X., et al. Rapid quantification of DNA methylation by measuring relative peak heights in direct bisulfite-PCR sequencing traces. Lab Invest 2010, 90:282-290.
25. Matthews J.O., Southern L.L., Higbie A.D., Persica M.A., Bidner T.D. Effects of betaine on growth, carcass characteristics, pork quality, and plasma metabolites of finishing pigs. J Anim Sci 2001, 79(3):722-728.
26. Rakhshandehroo M., Hooiveld G., Muller M., Kersten S. Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human. PLoS One 2009, 4:e6796.
27. Fischer M., You M., Matsumoto M., Crabb D.W. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J Biol Chem 2003, 278:27997-28004.
28. Wetterau J.R., Aggerbeck L.P., Bouma M.E., Eisenberg C., Munck A., Hermier M., et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 1992, 258:999-1001.
29. Sookoian S., Rosselli M.S., Gemma C., Burgueno A.L., Fernandez G.T., Castano G.O., et al. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor gamma coactivator 1alpha promoter. Hepatology 2010, 52:1992-2000.
30. Fujiki K., Kano F., Shiota K., Murata M. Expression of the peroxisome proliferator activated receptor gamma gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes. BMC Biol 2009, 7:38.
31. Brena R.M., Huang T.H., Plass C. Quantitative assessment of DNA methylation: potential applications for disease diagnosis, classification, and prognosis in clinical settings. J Mol Med (Berl). 2006, 84:365-377.
32. Chen R.Z., Pettersson U., Beard C., Jackson-Grusby L., Jaenisch R. DNA hypomethylation leads to elevated mutation rates. Nature 1998, 395:89-93.
33. Wainfan E., Dizik M., Stender M., Christman J.K. Rapid appearance of hypomethylated DNA in livers of rats fed cancer-promoting, methyl-deficient diets. Cancer Res 1989, 49:4094-4097.
34. Dumas M.E., Barton R.H., Toye A., Cloarec O., Blancher C., Rothwell A., et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A 2006, 103:12511-12516.
35. Kim J.M., Hong K., Lee J.H., Lee S., Chang N. Effect of folate deficiency on placental DNA methylation in hyperhomocysteinemic rats. J Nutr Biochem 2009, 20:172-176.
36. Bravo E., Palleschi S., Aspichueta P., Buque X., Rossi B., Cano A., et al. High fat diet-induced non alcoholic fatty liver disease in rats is associated with hyperhomocysteinemia caused by down regulation of the transsulphuration pathway. Lipids Health Dis 2011, 10:60.
37. Kangaspeska S., Stride B., Metivier R., Polycarpou-Schwarz M., Ibberson D., Carmouche R.P., et al. Transient cyclical methylation of promoter DNA. Nature 2008, 452:112-115.
38. Ooi S.K., Bestor T.H. The colorful history of active DNA demethylation. Cell 2008, 133:1145-1148.
39. Ghoshal K., Li X., Datta J., Bai S., Pogribny I., Pogribny M., et al. A folate- and methyl-deficient diet alters the expression of DNA methyltransferases and methyl CpG binding proteins involved in epigenetic gene silencing in livers of F344 rats. J Nutr 2006, 136:1522-1527.
40. Kovacheva V.P., Mellott T.J., Davison J.M., Wagner N., Lopez-Coviella I., Schnitzler A.C., et al. Gestational choline deficiency causes global and Igf2 gene DNA hypermethylation by up-regulation of Dnmt1 expression. J Biol Chem 2007, 282:31777-31788.
41. de Assis S., Warri A., Cruz M.I., Laja O., Tian Y., Zhang B., et al. High-fat or ethinyl-oestradiol intake during pregnancy increases mammary cancer risk in several generations of offspring. Nat Commun 2012, 3:1053.